Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma

Author:

Jacquelot NicolasORCID,Seillet CyrilORCID,Wang Minyu,Pizzolla AngelaORCID,Liao Yang,Hediyeh-zadeh SoroorORCID,Grisaru-Tal Sharon,Louis CynthiaORCID,Huang Qiutong,Schreuder JaringORCID,Souza-Fonseca-Guimaraes Fernando,de Graaf Carolyn A.,Thia Kevin,Macdonald Sean,Camilleri Mary,Luong KylieORCID,Zhang ShengboORCID,Chopin Michael,Molden-Hauer Tristan,Nutt Stephen L.ORCID,Umansky Viktor,Ciric Bogoljub,Groom Joanna R.ORCID,Foster Paul S.,Hansbro Philip M.ORCID,McKenzie Andrew N. J.ORCID,Gray Daniel H. D.ORCID,Behren Andreas,Cebon Jonathan,Vivier EricORCID,Wicks Ian P.ORCID,Trapani Joseph A.,Munitz ArielORCID,Davis Melissa J.ORCID,Shi Wei,Neeson Paul J.ORCID,Belz Gabrielle T.ORCID

Funder

Department of Health | National Health and Medical Research Council

University of Queensland

Cure Cancer Australia Foundation

Australian Government Research Training Program

Deutsche Forschungsgemeinschaft

Centenary Fellowship Walter and Eliza Hall Institute

RCUK | Medical Research Council

Victorian Cancer Agency

John T. Reid Charitable Trusts

Israel Science Foundation

Israel Cancer Research Fund

TAU | Cancer Biology Research Center, Tel Aviv University

Melbourne Research Scholarship

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3